Sermorelin + GHRP-6 10mg Blend
CAS: 86168-78-7 / 87616-84-0
Sermorelin + GHRP-6 10mg Blend by BioPeptides is a research-grade peptide formulation combining a growth hormone–releasing hormone (GHRH) analog with a growth hormone–releasing peptide (GHRP). The blend is designed for laboratory investigations into growth hormone signaling pathways, peptide-receptor activation, and endocrine communication mechanisms. Produced using precision peptide synthesis and analytically verified for stability and purity, this blend supports reproducible experimental models studying dual-pathway GH signaling.
$235.00
Research Use Only
Research Overview
The Sermorelin & GHRP-6 blend is a dual-peptide formulation studied in laboratory environments focused on growth hormone signaling mechanisms.
Researchers examine the combined activity of GHRH receptor signaling and ghrelin receptor signaling within endocrine communication systems.
The blend enables investigation of complementary peptide pathways influencing growth hormone regulation.
It contributes to broader research exploring multi-pathway peptide signaling in endocrine and pituitary research models.
Scientific Background
Growth hormone release is regulated by complex signaling pathways involving both GHRH and ghrelin receptor mechanisms.
Sermorelin functions as a synthetic analog of growth hormone–releasing hormone studied for GHRH receptor signaling.
GHRP-6 interacts with ghrelin (GHS-R) receptors, representing an alternative GH-regulating pathway.
Combining these peptides allows researchers to examine signaling synergy and pathway convergence in controlled research models.
Mechanistic Research Perspective
- GHRH receptor signaling pathway research
- Ghrelin receptor (GHS-R) activation studies
- Dual-pathway growth hormone signaling analysis
- Peptide-receptor interaction dynamics
- Endocrine regulatory pathway investigations
Primary Research Applications
Growth Hormone Signaling Research: Used to investigate GH release mechanisms through combined GHRH and ghrelin receptor activation.
Endocrine Pathway Studies: Researchers analyze peptide-mediated hormonal signaling pathways and pituitary communication systems.
Peptide-Receptor Interaction Research: Applied in laboratory assays examining receptor binding, pathway activation, and signaling specificity.
Comparative GH Peptide Research: Supports comparisons between single-pathway peptides and dual-pathway peptide combinations.
Exploratory Endocrine Research: Used in controlled non-clinical research models examining hormone regulatory signaling.
Molecular Characteristics
- Compound Name: Sermorelin + GHRP-6 Blend
- Sermorelin CAS Number: 86168-78-7
- GHRP-6 CAS Number: 87616-84-0
- Peptide Class: Growth hormone signaling peptides
- Form: Lyophilized peptide powder blend
- Unit Size: 10 mg research blend
Stability Profile and Storage Recommendations
- Store lyophilized peptide blend at −20°C
- Protect from moisture and direct light exposure
- Avoid repeated freeze–thaw cycles
- Reconstitute using sterile laboratory-grade solvent
- Seal vial tightly after each use
Solubility and Preparation Considerations
- Soluble in sterile aqueous laboratory solutions
- Compatible with buffered peptide research systems
- Applicable in endocrine pathway assays
- Suitable for receptor signaling experiments
- Compatible with molecular biology and peptide research protocols
Technical Specifications
product Name
Sermorelin + GHRP-6 10mg Blend
brand
BioPeptides
purity
Research-grade analytical quality
form
Lyophilized peptide powder blend
synthesis
Solid-phase peptide synthesis (SPPS)
analytical
Identity and purity verification
molecular Structure
Dual-peptide GH signaling formulation
stability
Stable under −20°C storage conditions
Analytical Validation and Quality Assurance
- Molecular identity verification of both peptides
- Purity and stability assessment
- Structural integrity testing
- Batch-to-batch consistency validation
- Analytical quality control inspection
Frequently Asked Questions
The blend is used in laboratory studies examining growth hormone signaling through both GHRH receptor and ghrelin receptor pathways.
Combining these peptides allows researchers to investigate complementary GH-stimulating mechanisms and pathway synergy.
Yes. It is commonly used in controlled laboratory experiments analyzing receptor activation and endocrine signaling pathways.
The blend is studied in endocrinology research, peptide signaling studies, molecular biology, and exploratory hormone pathway research.
The 10mg research format supports extended experimental protocols while reducing variability between peptide batches.
It should be stored at −20°C and protected from light and moisture.